Cellredm
Cellredm (셀르디엠, CellREDM) is an injectable skin product made from donated human skin that has had its cells removed (human acellular dermal matrix). It is from Hans Biomed and distributed in Korea by Hugel. No published studies or official approval records for this specific product were found, so its benefits and risks are not yet well documented.
On this page
Overview

What it is
CellREDM (셀르디엠) is an injectable product made from human acellular dermal matrix (hADM). This is donated human skin from which the cells have been removed, leaving supporting materials such as collagen and elastin [2] [3]. Trade reports describe it as an extracellular matrix (ECM) product meant to help restore skin structure. It is promoted for skin regeneration rather than for filling wrinkles or adding volume [2] [3].
In April 2026, Hugel signed an agreement with Hans Biomed to distribute CellREDM in Korea. Hans Biomed's tissue-processing technology is behind the product [2] [3]. Other hADM skin boosters are sold in Korea under different names. They are separate products, so check the exact product name.
What it involves
CellREDM is injected into the skin. Trade reports say it can be used alongside hyaluronic acid fillers [2] [3]. No published treatment protocol was found, so the injection method, number of sessions and spacing depend on the clinic. Ask the clinician to explain their plan.
Reasons to discuss it with a clinician and limits
People may ask about ECM skin boosters for skin quality, texture or firmness. For CellREDM specifically, no published clinical studies or official approval records were found for this guide. The available reports are business news about the distribution deal [2] [3]. The companies say they will highlight less downtime and pain after treatment. These are marketing statements without supporting data [2] [3]. Any benefit, and how long it lasts, is therefore unconfirmed. A clinician can compare it with better-studied options.
Risks and considerations
No safety data specific to CellREDM were found. As a general guide to injecting material into the skin, FDA information on dermal fillers lists common effects such as bruising, redness, swelling, pain, tenderness, itching and rash. Less common problems include lumps, infection, allergic reaction and tissue death. The most serious risk is accidental injection into a blood vessel, which is uncommon but can cause tissue death, stroke or blindness and may be permanent [1]. Some injected materials are hard to remove if problems occur [1]. This is general filler guidance, not evidence about this product.
Because hADM comes from human donors, its safety also depends on donor screening, infection testing, sterile processing and tracking each donor's tissue. A 2026 conference talk in Korea described these controls for hADM tissue in general [4]. Hans Biomed holds tissue bank accreditation from the American Association of Tissue Banks [2]. This is a quality standard for the tissue bank, not an approval of the product.
Recovery and follow-up
No recovery timeline specific to this product was found. Claims of shorter downtime come from the companies [2] [3]. Ask the clinic what reactions to expect, how long they usually last, and who to contact if swelling, lumps, skin colour changes or pain develop, including after you leave Korea.
Questions to ask
- Is the product CellREDM (셀르디엠), and can I see the packaging and lot information?
- What is its approval or permit status in Korea?
- What evidence exists for this product, and what results have you seen?
- Will it be combined with a filler or other injectable, and why?
- How many sessions do you suggest?
- What side effects have you seen, and how would a lump or vascular problem be managed?
Educational information. AI editorial and source checking are not clinical review. Checked 16 Nov 2026.
- Category
- Skin
- General estimate
- Not availableNo reviewed estimate exists. Clinic prices, when published, appear on each clinic profile.
Doctors who list cellredm
No doctors documented for this procedure yet.
A doctor appears here only when their scope is documented for this procedure at an exact clinic location.
Clinics that list cellredm
Offering evidence from each clinic’s own website. Availability and suitability need confirmation with the clinic.
No clinics list it yet.
Sources
Clinical references
- Dermal Filler Do's and Don'ts for Wrinkles, Lips and More · U.S. Food and Drug Administration (FDA) · Checked 16 Nov 2026
- 휴젤, ECM 기반 셀르디엠 판권 확보…포트폴리오 확장 · Dailypharm · Checked 16 Nov 2026
- Hugel Partners with Hans Biomed to Enter ECM Skin Booster Market · Seoul Economic Daily · Checked 16 Nov 2026
- hADM 안전성, 기증부터 추적까지 전주기 관리체계로 검증 · Dailypharm · Checked 16 Nov 2026
- Catalogue source
- Source
This page is for research. It is not medical advice and is not a recommendation. Whether a treatment suits you, its risks and its cost need an individual consultation with a licensed doctor.
Online correction reports are not open yet.